Our findings revealed the molecular mechanisms of CX3CL1-induced VMEC barrier disruption and provided new insight into the role of CX3CL1 on tumor cells TEM via its regulatory effects on vertebral micro-vasculature, which may provide new therapeutic directions for circulating tumor cell TEM in the spine. This evidence concerns the gene CX3CL1 and neoplasm.